Clinical trial
Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause…
NCT00418249 · Rabin Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00418249 |
|---|---|
| Title | Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women |
| Official title | Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women |
| Lead sponsor | Rabin Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alopecia |
| Intervention type | Drug |
| Interventions | AS101 |
| Enrollment | 40 |
| First posted | Jan 4, 2007 |
| Last update posted | Jan 4, 2007 |
| Countries | Israel |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: